-
Global RET Inhibitors Drug Market Opportunity & Clinical Trials Insight 2026 Published: March, 2021 - Pages: 150 - US$ 2,400.00 COVID-19 update included[CovidUpdated]
-
Angiosarcoma - Global Clinical Trials Review, H1, 2021 Published: March, 2021 - Pages: 153 - US$ 2,500.00 COVID-19 update included[CovidUpdated]
-
Esophageal Varices - Global Clinical Trials Review, H1, 2021 Published: March, 2021 - Pages: 100 - US$ 2,500.00 COVID-19 update included[CovidUpdated]
-
Fasciitis - Global Clinical Trials Review, H1, 2021 Published: March, 2021 - Pages: 97 - US$ 2,500.00 COVID-19 update included[CovidUpdated]
-
Rhinosinusitis - Global Clinical Trials Review, H1, 2021 Published: March, 2021 - Pages: 237 - US$ 2,500.00 COVID-19 update included[CovidUpdated]
-
Vaginal Cancer - Global Clinical Trials Review, H1, 2021 Published: March, 2021 - Pages: 111 - US$ 2,500.00 COVID-19 update included[CovidUpdated]
-
Lennox-Gastaut Syndrome - Global Clinical Trials Review, H1, 2021 Published: April, 2021 - Pages: 130 - US$ 2,500.00 COVID-19 update included[CovidUpdated]
-
Amenorrhea - Global Clinical Trials Review, H1, 2021 Published: April, 2021 - Pages: 133 - US$ 2,500.00 COVID-19 update included[CovidUpdated]
-
Glioblastoma Multiforme (GBM) - Global Clinical Trials Review, H1, 2021 Published: April, 2021 - Pages: 1181 - US$ 2,500.00 COVID-19 update included[CovidUpdated]
-
Plaque Psoriasis (Psoriasis Vulgaris) - Global Clinical Trials Review, H1, 2021 Published: April, 2021 - Pages: 940 - US$ 2,500.00 COVID-19 update included[CovidUpdated]